US 11759525
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11759525 (Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy) held by Dyne Therapeutics, Inc. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K38/00, A61K47/6807